Possible role for furazolidone in the treatment of glioblastoma multiforme

J BUON. Oct-Dec 2013;18(4):1097.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Aldehyde Dehydrogenase / antagonists & inhibitors*
  • Aldehyde Dehydrogenase / metabolism
  • Aldehyde Dehydrogenase 1 Family
  • Antineoplastic Agents / therapeutic use*
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / enzymology
  • Brain Neoplasms / pathology
  • Enzyme Inhibitors / therapeutic use*
  • Furazolidone / therapeutic use*
  • Glioblastoma / drug therapy*
  • Glioblastoma / enzymology
  • Glioblastoma / pathology
  • Humans
  • Retinal Dehydrogenase
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Furazolidone
  • Aldehyde Dehydrogenase 1 Family
  • Aldehyde Dehydrogenase
  • ALDH1A1 protein, human
  • Retinal Dehydrogenase

Associated data

  • ClinicalTrials.gov/NCT01777919
  • ClinicalTrials.gov/NCT01907165